For those individuals suffering with diabetes, the hope of dealing with it without injections of insulin is enormous. An inhaled insulin delivery system would be an important improvement.

“Pfizer, the world’s biggest drug company, flopped miserably with a seemingly can’t-miss idea. Pfizer’s failure was a form of insulin that people with diabetes could inhale rather than inject. But last month, after selling only $12 million worth of inhaled insulin in the first nine months of the year, Pfizer said it would take a $2.8 billion charge and abandon the product.”

“Alfred E. Mann is betting nearly $1 billion of his own money that he can succeed where Pfizer failed.”
[read whole story]